You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 129 No. 2, February 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Challenges in Otolaryngology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Dentistry/ Oral Medicine
 •Radiation Therapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Xerostomia Prevention After Head and Neck Cancer Treatment

Arch Otolaryngol Head Neck Surg. 2003;129:250-251.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Xerostomia is a serious problem that impacts patients' quality of life negatively. Salivary gland dysfunction impairs mastication, deglutition, and gustation while heightening the susceptibility of the oral hard and soft tissues to a variety of destructive processes. Drs Nagler and Baum have presented a good summary of the theories of salivary gland irradiation damage and a comprehensive review of the pharmacologic manipulation used in preserving salivary function during radiation. The concept of gene transfer is intriguing but it is unlikely to be of clinical use for many years. There are, however, numerous methods presently available to the clinician that effectively preserve salivary function and, in some patients, prevent posttreatment xerostomia. These methods can be broadly classified into 3 categories: chemoprevention, parotid gland sparing, and submandibular and sublingual gland sparing.


 
Figure appears in full text version.
Hadi Seikaly, MD


CHEMOPREVENTION

This topic has been well covered by Drs Nagler and Baum. The 2 agents most commonly used in . . . [Full Text of this Article]

PAROTID GLAND SPARING

SUBMANDIBULAR AND SUBLINGUAL GLAND SPARING



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Prophylactic Treatment Reduces the Severity of Xerostomia Following Radiation Therapy for Oral Cavity Cancer
Rafael M. Nagler and Bruce J. Baum
Arch Otolaryngol Head Neck Surg. 2003;129(2):247-250.
EXTRACT | FULL TEXT  

Clinical Commentary on Prophylactic Treatment of Radiation-Induced Xerostomia
Mark S. Chambers
Arch Otolaryngol Head Neck Surg. 2003;129(2):251-252.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.